U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07899892) titled 'A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer' on Oct. 21.

Brief Summary: The purpose of this study is to find out whether it is practical (feasible) to use a new type of imaging scan called 68Ga-FAPI PET/MRI (positron emission tomography/magnetic resonance imaging) to evaluate how well breast cancer responds to neoadjuvant chemotherapy.

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Breast Cancer Invasive Breast Cancer

Intervention: DIAGNOSTIC_TEST: 68Ga-FAPI-PET/MRI

68Ga-FAPI-PET/MRI is conducted 3 times in every participant.

Recruitment Status: RECRUITING

Sponsor: Memorial Sloan ...